
William P. Neuder
Examiner (ID: 10341)
| Most Active Art Unit | 3672 |
| Art Unit(s) | 3672, 2899, 3625, 3642, 3506 |
| Total Applications | 4583 |
| Issued Applications | 4090 |
| Pending Applications | 166 |
| Abandoned Applications | 332 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18784749
[patent_doc_number] => 20230372374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => VETERINARY PHARMACEUTICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/318133
[patent_app_country] => US
[patent_app_date] => 2023-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18318133
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/318133 | VETERINARY PHARMACEUTICAL FORMULATIONS | May 15, 2023 | Pending |
| 18/144220 | NOVEL ISOXAZOLINE COMPLEXES AND COMPOSITIONS THEREOF | May 6, 2023 | Abandoned |
Array
(
[id] => 18581481
[patent_doc_number] => 20230263733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => Solid Oral Sulfate Salt Formulations For Cleaning A Colon And Methods of Using Same
[patent_app_type] => utility
[patent_app_number] => 18/141610
[patent_app_country] => US
[patent_app_date] => 2023-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18141610
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/141610 | Solid Oral Sulfate Salt Formulations For Cleaning A Colon And Methods of Using Same | Apr 30, 2023 | Pending |
Array
(
[id] => 18707591
[patent_doc_number] => 20230330168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => COMPOSITION FOR IMPROVING EYESIGHT
[patent_app_type] => utility
[patent_app_number] => 18/134050
[patent_app_country] => US
[patent_app_date] => 2023-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18134050
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/134050 | Composition for improving eyesight | Apr 12, 2023 | Issued |
Array
(
[id] => 19032566
[patent_doc_number] => 20240082381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => PHARMACEUTICAL COMPOSITIONS, COMPRISING OF SELECT CARRIERS, VITAMINS, TANNINS AND FLAVONOIDS AS ANTIGEN-SPECIFIC IMMUNO-MODULATORS
[patent_app_type] => utility
[patent_app_number] => 18/130108
[patent_app_country] => US
[patent_app_date] => 2023-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18130108
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/130108 | PHARMACEUTICAL COMPOSITIONS, COMPRISING OF SELECT CARRIERS, VITAMINS, TANNINS AND FLAVONOIDS AS ANTIGEN-SPECIFIC IMMUNO-MODULATORS | Apr 2, 2023 | Pending |
Array
(
[id] => 18483507
[patent_doc_number] => 20230210804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
[patent_app_type] => utility
[patent_app_number] => 18/120231
[patent_app_country] => US
[patent_app_date] => 2023-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 103274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18120231
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/120231 | MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS | Mar 9, 2023 | Abandoned |
Array
(
[id] => 18938147
[patent_doc_number] => 20240033286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => EMOLLIENT TOPICAL DISINFECTANTS
[patent_app_type] => utility
[patent_app_number] => 18/179283
[patent_app_country] => US
[patent_app_date] => 2023-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18179283
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/179283 | EMOLLIENT TOPICAL DISINFECTANTS | Mar 5, 2023 | Abandoned |
Array
(
[id] => 18893773
[patent_doc_number] => 20240009258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => ANTI-CANCER COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/162038
[patent_app_country] => US
[patent_app_date] => 2023-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18162038
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/162038 | ANTI-CANCER COMPOSITION AND USE THEREOF | Jan 30, 2023 | Pending |
Array
(
[id] => 18374416
[patent_doc_number] => 20230149495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => MODULATION OF NCRNAS, LYMPHOCYTES, NEUTROPHILS, INFLAMMASOMES AND P53
[patent_app_type] => utility
[patent_app_number] => 18/099118
[patent_app_country] => US
[patent_app_date] => 2023-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18099118
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/099118 | MODULATION OF NCRNAS, LYMPHOCYTES, NEUTROPHILS, INFLAMMASOMES AND P53 | Jan 18, 2023 | Pending |
Array
(
[id] => 18418435
[patent_doc_number] => 20230172893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
[patent_app_type] => utility
[patent_app_number] => 18/096508
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 103285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18096508
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/096508 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Jan 11, 2023 | Issued |
Array
(
[id] => 18366352
[patent_doc_number] => 20230147943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => TABLETS HAVING DISCONTINUOUS COATED REGIONS
[patent_app_type] => utility
[patent_app_number] => 18/150741
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150741
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150741 | TABLETS HAVING DISCONTINUOUS COATED REGIONS | Jan 4, 2023 | Pending |
Array
(
[id] => 18522988
[patent_doc_number] => 20230233641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => ORAL GEL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/093654
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18093654
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/093654 | ORAL GEL COMPOSITIONS | Jan 4, 2023 | Pending |
Array
(
[id] => 18495973
[patent_doc_number] => 20230218493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => ANTI-AGING FORMULA
[patent_app_type] => utility
[patent_app_number] => 18/091578
[patent_app_country] => US
[patent_app_date] => 2022-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18091578
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/091578 | ANTI-AGING FORMULA | Dec 29, 2022 | Pending |
Array
(
[id] => 19584995
[patent_doc_number] => 20240382552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING SLEEP DISORDER OR INSOMNIA, CONTAINING EXTRACT OF ROASTED CITRUS BYPRODUCT AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 18/033699
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033699
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033699 | COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING SLEEP DISORDER OR INSOMNIA, CONTAINING EXTRACT OF ROASTED CITRUS BYPRODUCT AS ACTIVE INGREDIENT | Dec 20, 2022 | Pending |
Array
(
[id] => 19246817
[patent_doc_number] => 20240197801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => Liver Vitality
[patent_app_type] => utility
[patent_app_number] => 18/083477
[patent_app_country] => US
[patent_app_date] => 2022-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18083477
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/083477 | Liver Vitality | Dec 16, 2022 | Pending |
Array
(
[id] => 18647846
[patent_doc_number] => 20230293622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => SAUVIGNON BLANC GRAPE SEED PRODUCTS FOR NONALCOHOLIC FATTY LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/063281
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063281
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063281 | SAUVIGNON BLANC GRAPE SEED PRODUCTS FOR NONALCOHOLIC FATTY LIVER DISEASE | Dec 7, 2022 | Pending |
Array
(
[id] => 18418434
[patent_doc_number] => 20230172892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
[patent_app_type] => utility
[patent_app_number] => 18/075980
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 103128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18075980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/075980 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Dec 5, 2022 | Issued |
Array
(
[id] => 18282880
[patent_doc_number] => 20230098352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHOD OF INCREASING BIOAVAILABILITY AND/OR PROLONGING OPHTHALMIC ACTION OF A DRUG
[patent_app_type] => utility
[patent_app_number] => 18/061848
[patent_app_country] => US
[patent_app_date] => 2022-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061848
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061848 | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug | Dec 4, 2022 | Issued |
Array
(
[id] => 19722086
[patent_doc_number] => 20250024837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => PESTICIDE SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/711564
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -106
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18711564
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/711564 | PESTICIDE SYSTEM | Nov 20, 2022 | Pending |
Array
(
[id] => 18360595
[patent_doc_number] => 20230142186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => Rucaparib particles and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/053557
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053557
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053557 | Rucaparib particles and uses thereof | Nov 7, 2022 | Issued |